143 related articles for article (PubMed ID: 9305187)
21. Molecular genetic differentiation between primary lung cancers and lung metastases of other tumors.
Kandioler D; Dekan G; End A; Pasching E; Buchmayer H; Gnant M; Langmann F; Mannhalter C; Eckersberger F; Wolner E
J Thorac Cardiovasc Surg; 1996 Apr; 111(4):827-31; discussion 832. PubMed ID: 8614143
[TBL] [Abstract][Full Text] [Related]
22. Second primary cancers after resection of lung adenocarcinoma with ras gene mutation.
Sugio K; Fukuyama Y; Sakada T; Nishioka K; Yamazaki K; Ushijima C; Tsukamoto S; Ishida T; Sugimachi K
Anticancer Res; 1998; 18(5A):3395-8. PubMed ID: 9858914
[TBL] [Abstract][Full Text] [Related]
23. p53 null mutations undetected by immunohistochemical staining predict a poor outcome with early-stage non-small cell lung carcinomas.
Hashimoto T; Tokuchi Y; Hayashi M; Kobayashi Y; Nishida K; Hayashi S; Ishikawa Y; Tsuchiya S; Nakagawa K; Hayashi J; Tsuchiya E
Cancer Res; 1999 Nov; 59(21):5572-7. PubMed ID: 10554037
[TBL] [Abstract][Full Text] [Related]
24. Synchronous primary lung cancer presenting with small cell carcinoma and non-small cell carcinoma: diagnosis and treatment.
Hiraki A; Ueoka H; Yoshino T; Chikamori K; Onishi K; Kiura K; Bessho A; Mimoto J; Date H; Ando A; Shimizu N; Harada M
Oncol Rep; 1999; 6(1):75-80. PubMed ID: 9864405
[TBL] [Abstract][Full Text] [Related]
25. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
[TBL] [Abstract][Full Text] [Related]
26. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
Huang C; Taki T; Adachi M; Konishi T; Higashiyama M; Miyake M
Oncogene; 1998 May; 16(19):2469-77. PubMed ID: 9627113
[TBL] [Abstract][Full Text] [Related]
27. Detection of p53 gene mutations in cytopathology and biopsy specimens from patients with lung cancer.
Murakami I; Fujiwara Y; Yamaoka N; Hiyama K; Ishioka S; Yamakido M
Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):1117-23. PubMed ID: 8887616
[TBL] [Abstract][Full Text] [Related]
28. Topoisomerase IIalpha gene expression is regulated by the p53 tumor suppressor gene in nonsmall cell lung carcinoma patients.
Liu D; Huang CL; Kameyama K; Hayashi E; Yamauchi A; Sumitomo S; Yokomise H
Cancer; 2002 Apr; 94(8):2239-47. PubMed ID: 12001123
[TBL] [Abstract][Full Text] [Related]
29. High frequency of frameshift mutation on p53 gene in Taiwanese with non small cell lung cancer.
Chang MY; Chong IW; Chen FM; Wang JY; Cheng TL; Cheng YJ; Sheu CC; Hung SY; Yang MC; Lin SR
Cancer Lett; 2005 May; 222(2):195-204. PubMed ID: 15863268
[TBL] [Abstract][Full Text] [Related]
30. [Analysis of mutation types of p53 gene and possible carcinogenic factors in lung cancer].
Gao ZQ; Gao Z; Zhang X
Zhonghua Yu Fang Yi Xue Za Zhi; 1997 Mar; 31(2):88-91. PubMed ID: 9812619
[TBL] [Abstract][Full Text] [Related]
31. P53 and K-ras mutations are frequent events in microscopically negative surgical margins from patients with nonsmall cell lung carcinoma.
Jassem J; Jassem E; Jakóbkiewicz-Banecka J; Rzyman W; Badzio A; Dziadziuszko R; Kobierska-Gulida G; Szymanowska A; Skrzypski M; Zylicz M
Cancer; 2004 May; 100(9):1951-60. PubMed ID: 15112277
[TBL] [Abstract][Full Text] [Related]
32. Multiple primary tumors of the upper aerodigestive tract: is there a role for constitutional mutations in the p53 gene?
Gallo O; Sardi I; Pepe G; Franchi A; Attanasio M; Giusti B; Bocciolini C; Abbate R
Int J Cancer; 1999 Jul; 82(2):180-6. PubMed ID: 10389749
[TBL] [Abstract][Full Text] [Related]
33. Genetic evidence for an independent origin of multiple preneoplastic and neoplastic lung lesions.
Sozzi G; Miozzo M; Pastorino U; Pilotti S; Donghi R; Giarola M; De Gregorio L; Manenti G; Radice P; Minoletti F
Cancer Res; 1995 Jan; 55(1):135-40. PubMed ID: 7805023
[TBL] [Abstract][Full Text] [Related]
34. Second primary or recurrence? Comparative patterns of p53 and K-ras mutations suggest that serous borderline ovarian tumors and subsequent serous carcinomas are unrelated tumors.
Ortiz BH; Ailawadi M; Colitti C; Muto MG; Deavers M; Silva EG; Berkowitz RS; Mok SC; Gershenson DM
Cancer Res; 2001 Oct; 61(19):7264-7. PubMed ID: 11585764
[TBL] [Abstract][Full Text] [Related]
35. [Mutations of p53 gene exons 5 to 8 in human ovarian cancer and its clinical significance].
You Z; Guo Y; Wen H
Zhonghua Fu Chan Ke Za Zhi; 1996 Nov; 31(11):660-3. PubMed ID: 9387525
[TBL] [Abstract][Full Text] [Related]
36. [Detection of p53 gene mutation in paraffin-embedded asbestos-related lung cancer tissue].
Fu D; Liu B; Wang H
Zhonghua Yu Fang Yi Xue Za Zhi; 1997 Jul; 31(4):206-8. PubMed ID: 9812577
[TBL] [Abstract][Full Text] [Related]
37. Analysis of p53 gene mutation by polymerase chain reaction-single strand conformation polymorphism provides independent prognostic information in node-negative breast cancer.
Iacopetta B; Grieu F; Powell B; Soong R; McCaul K; Seshadri R
Clin Cancer Res; 1998 Jul; 4(7):1597-602. PubMed ID: 9676832
[TBL] [Abstract][Full Text] [Related]
38. Genetic changes in contralateral bronchioloalveolar carcinomas of the lung.
Shin SW; Breathnach OS; Linnoila RI; Williams J; Gillespie JW; Kelley MJ; Johnson BE
Oncology; 2001; 60(1):81-7. PubMed ID: 11150913
[TBL] [Abstract][Full Text] [Related]
39. p53 mutations in lung cancer following radiation therapy for Hodgkin's disease.
De Benedetti VM; Travis LB; Welsh JA; van Leeuwen FE; Stovall M; Clarke EA; Boice JD; Bennett WP
Cancer Epidemiol Biomarkers Prev; 1996 Feb; 5(2):93-8. PubMed ID: 8850268
[TBL] [Abstract][Full Text] [Related]
40. [Detection of p53 gene alteration in sputum sample and its implications in early diagnosis of lung cancer].
Wang B; Li L; Yao L; Liu L; Zhu Y
Zhonghua Nei Ke Za Zhi; 2001 Feb; 40(2):101-4. PubMed ID: 11798563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
